Trial Profile
Realtive Bioavailability and pharmacokinetic profiling of a generic darifenacin formulation [Darisec extended release 15 mg] vs. the innovator [Enablex 15 mg] in healthy fed volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Darifenacin (Primary)
- Indications Overactive bladder
- Focus Pharmacokinetics
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 27 Jul 2011 New trial record